Literature DB >> 32192985

Alignment of Transcatheter Aortic-Valve Neo-Commissures (ALIGN TAVR): Impact on Final Valve Orientation and Coronary Artery Overlap.

Gilbert H L Tang1, Syed Zaid2, Andreas Fuchs3, Tsuyoshi Yamabe4, Farhang Yazdchi5, Eisha Gupta6, Hasan Ahmad2, Klaus F Kofoed7, Joshua B Goldberg8, Cenap Undemir8, Ryan K Kaple9, Pinak B Shah10, Tsuyoshi Kaneko5, Steven L Lansman8, Sahil Khera6, Jason C Kovacic6, George D Dangas6, Stamatios Lerakis6, Samin K Sharma6, Annapoorna Kini6, David H Adams11, Omar K Khalique12, Rebecca T Hahn12, Lars Søndergaard3, Isaac George4, Susheel K Kodali12, Ole De Backer3, Martin B Leon12, Vinayak N Bapat4.   

Abstract

OBJECTIVES: The aim of this study was to evaluate the impact of initial deployment orientation of SAPIEN 3, Evolut, and ACURATE-neo transcatheter heart valves on their final orientation and neocommissural overlap with coronary arteries.
BACKGROUND: Coronary artery access and redo transcatheter aortic valve replacement (TAVR) following initial TAVR may be influenced by transcatheter heart valve orientation. In this study the impact of transcatheter heart valve deployment orientation on commissural alignment was evaluated.
METHODS: Pre-TAVR computed tomography and procedural fluoroscopy were analyzed in 828 patients who underwent TAVR (483 SAPIEN 3, 245 Evolut, and 100 ACURATE-neo valves) from March 2016 to September 2019 at 5 centers. Coplanar fluoroscopic views were coregistered to pre-TAVR computed tomography to determine commissural alignment. Severe overlap between neocommissural posts and coronary arteries was defined as 0° to 20° apart. The SAPIEN 3 had 1 commissural post crimped at 3, 6, 9, and 12 o'clock. The Evolut "Hat" marker and ACURATE-neo commissural post at deployment were classified as center back (CB), inner curve (IC), outer curve (OC), or center front (CF) and matched with final orientation.
RESULTS: Initial SAPIEN 3 crimped orientation had no impact on commissural alignment. Evolut "Hat" at OC or CF at initial deployment had less severe overlap than IC or CB (p < 0.001) against the left main (15.7% vs. 66.0%) and right coronary (7.1% vs. 51.1%) arteries. Tracking Evolut "Hat" at OC of the descending aorta (n = 107) improved OC at deployment from 70.2% to 91.6% (p = 0.002) and reduced coronary artery overlap by 36% to 60% (p < 0.05). ACURATE-neo commissural post at CB or IC during deployment had less coronary artery overlap compared to CF or OC (p < 0.001), with intentional alignment successful in 5 of 7 cases.
CONCLUSIONS: This is the first systematic evaluation of commissural alignment in TAVR. More than 30% to 50% of cases had overlap with 1 or both coronary arteries. Initial SAPIEN 3 orientation had no impact on alignment, but specific initial orientations of Evolut and ACURATE improved alignment. Optimizing valve alignment to avoid coronary artery overlap will be important in coronary artery access and redo TAVR.
Copyright © 2020 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  commissural alignment; coronary artery access; transcatheter aortic valve replacement

Year:  2020        PMID: 32192985     DOI: 10.1016/j.jcin.2020.02.005

Source DB:  PubMed          Journal:  JACC Cardiovasc Interv        ISSN: 1936-8798            Impact factor:   11.195


  13 in total

Review 1.  How to Image and Manage Prosthesis-Related Complications After Transcatheter Aortic Valve Replacement.

Authors:  Nina C Wunderlich; Jörg Honold; Martin J Swaans; Robert J Siegel
Journal:  Curr Cardiol Rep       Date:  2021-07-01       Impact factor: 2.931

2.  Coronary Artery Occlusion during Transcatheter Aortic Valve Implantation: Early Recognition Have Better Outcome.

Authors:  Mohamed Abdunasser M Baghi; Khaled Taufek Othman; Abdu Rahman H Alnabti; Salem M Abujalala
Journal:  Heart Views       Date:  2022-05-16

3.  Early Transcatheter Heart Valve Pannus Leading to Coronary Obstruction Managed With Orthotopic Chimney Stenting.

Authors:  Mariama Akodad; Anthony Chuang; Abdul Ihdayhid; Andrew G Chatfield; Jonathon Leipsic; Anson Cheung; David A Wood; Anthony Della Siega; M Bilal Iqbal; John G Webb; Janarthanan Sathananthan
Journal:  CJC Open       Date:  2022-02-01

4.  A patient-specific algorithm to achieve commissural alignment with Acurate Neo: The sextant technique.

Authors:  Federico De Marco; Matteo Casenghi; Pietro Spagnolo; Antonio Popolo Rubbio; Nedy Brambilla; Luca Testa; Francesco Bedogni
Journal:  Catheter Cardiovasc Interv       Date:  2021-05-07       Impact factor: 2.585

5.  Current challenges in TAVI: neo-commissural alignment to mimic more physiologic valve implantation.

Authors:  Aditya Sengupta; Sophia L Alexis; Jason C Kovacic; Gilbert H L Tang
Journal:  Vessel Plus       Date:  2020-12-10

Review 6.  The Use of BASILICA Technique to Prevent Coronary Obstruction in a TAVI-TAVI Procedure.

Authors:  Ana Paula Tagliari; Rodrigo Petersen Saadi; Eduardo Ferreira Medronha; Eduardo Keller Saadi
Journal:  J Clin Med       Date:  2021-11-26       Impact factor: 4.241

Review 7.  Commissural alignment in transcatheter aortic valve replacement: A literature review.

Authors:  Abdul Muiz Khalid; Crochan J O'Sullivan
Journal:  Front Cardiovasc Med       Date:  2022-08-09

Review 8.  Coronary Assessment and Revascularization Before Transcutaneous Aortic Valve Implantation: An Update on Current Knowledge.

Authors:  Muhammad Sabbah; Thomas Engstrøm; Ole De Backer; Lars Søndergaard; Jacob Lønborg
Journal:  Front Cardiovasc Med       Date:  2021-05-21

9.  A case report of open-aorta, direct transcatheter valve-in-valve implantation: an innovative approach to manage the hazard of coronary flow compromise in transcatheter aortic valve re-interventions.

Authors:  Domenico Calcaterra; Navneet Kaur; Gopika Dasari; George Daniel
Journal:  Eur Heart J Case Rep       Date:  2021-05-17

10.  Intentional Misalignment of a Transcatheter Aortic Valve to Preserve Reaccess to Coronaries of Anomalous Origin.

Authors:  Giuliano Costa; Carmelo Sgroi; Orazio Strazzieri; Claudia Reddavid; Roberto Valvo; Silvia Motta; Valentina Frittitta; Elena Dipietro; Corrado Tamburino; Marco Barbanti
Journal:  JACC Case Rep       Date:  2022-01-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.